North America Tissue Engineered Skin Substitutes Market Outlook to 2033 - Cellular Skin Substitutes and Acellular Skin Substitutes

Description

List of Tables

GlobalData's "North America Tissue Engineered Skin Substitutes Outlook to 2033" is a comprehensive databook report, covering key market data on the North America Tissue Engineered Skin Substitutes market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Cellular Skin Substitutes and Acellular Skin Substitutes

The North America Tissue Engineered Skin Substitutes Market report provides key information and data on -

Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
2024 company share data for Tissue Engineered Skin Substitutes Market.
Global corporate-level profiles of key companies operating within the North America Tissue Engineered Skin Substitutes Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

North America Tissue Engineered Skin Substitutes is segmented as follows -

Cellular Skin Substitutes
Acellular Skin Substitutes

Reasons to Buy

The North America Tissue Engineered Skin Substitutes Market report helps you to develop -

Business strategies by identifying the key market segments poised for strong growth in the future.
Market-entry and market expansion strategies.
Design competition strategies by identifying who-stands-where in the market.
Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

Product Code: GDME21584CRDB

1 Table of Contents

1.1 List of Tables
1.2 List of Figures

2 Introduction

2.1 What Is This Report About?
2.2 Tissue Engineered Skin Substitutes Market Segmentation
2.3 Definitions of Markets Covered in the Report

3 Tissue Engineered Skin Substitutes Market, North America

3.1 Tissue Engineered Skin Substitutes Market, North America, Revenue ($m), 2018-2033
3.2 Tissue Engineered Skin Substitutes Market, North America, Revenue ($m), 2018-2033
3.3 Tissue Engineered Skin Substitutes Market, North America, Volume (Units), 2018-2033
3.4 Tissue Engineered Skin Substitutes Market, North America, Volume (Units), 2018-2033
3.5 Tissue Engineered Skin Substitutes Market, North America, Company Share by Revenue ($m), 2024

4 Tissue Engineered Skin Substitutes Market, Canada

4.1 Tissue Engineered Skin Substitutes Market, Canada, Revenue ($m), 2018-2033
- 4.1.1 Acellular Skin Substitutes Market, Canada, Revenue ($m), by Segment, 2018-2033
- 4.1.2 Cellular Skin Substitutes Market, Canada, Revenue ($m), by Segment, 2018-2033
4.2 Tissue Engineered Skin Substitutes Market, Canada, Volume (Units), 2018-2033
- 4.2.1 Acellular Skin Substitutes Market, Canada, Volume (Units), by Segment, 2018-2033
- 4.2.2 Cellular Skin Substitutes Market, Canada, Volume (Units), by Segment, 2018-2033
4.3 Tissue Engineered Skin Substitutes Market, Canada, Average Price ($), 2018-2033
4.4 Tissue Engineered Skin Substitutes Market, Canada, Company Share by Revenue ($m), 2024

5 Tissue Engineered Skin Substitutes Market, Mexico

5.1 Tissue Engineered Skin Substitutes Market, Mexico, Revenue ($m), 2018-2033
- 5.1.1 Acellular Skin Substitutes Market, Mexico, Revenue ($m), by Segment, 2018-2033
- 5.1.2 Cellular Skin Substitutes Market, Mexico, Revenue ($m), by Segment, 2018-2033
5.2 Tissue Engineered Skin Substitutes Market, Mexico, Volume (Units), 2018-2033
- 5.2.1 Acellular Skin Substitutes Market, Mexico, Volume (Units), by Segment, 2018-2033
- 5.2.2 Cellular Skin Substitutes Market, Mexico, Volume (Units), by Segment, 2018-2033
5.3 Tissue Engineered Skin Substitutes Market, Mexico, Average Price ($), 2018-2033
5.4 Tissue Engineered Skin Substitutes Market, Mexico, Company Share by Revenue ($m), 2024

6 Tissue Engineered Skin Substitutes Market, United States

6.1 Tissue Engineered Skin Substitutes Market, United States, Revenue ($m), 2018-2033
- 6.1.1 Acellular Skin Substitutes Market, United States, Revenue ($m), by Segment, 2018-2033
- 6.1.2 Cellular Skin Substitutes Market, United States, Revenue ($m), by Segment, 2018-2033
6.2 Tissue Engineered Skin Substitutes Market, United States, Volume (Units), 2018-2033
- 6.2.1 Acellular Skin Substitutes Market, United States, Volume (Units), by Segment, 2018-2033
- 6.2.2 Cellular Skin Substitutes Market, United States, Volume (Units), by Segment, 2018-2033
6.3 Tissue Engineered Skin Substitutes Market, United States, Average Price ($), 2018-2033
6.4 Tissue Engineered Skin Substitutes Market, United States, Company Share by Revenue ($m), 2024

7 Overview of Key Companies in North America Tissue Engineered Skin Substitutes Market

7.1 Allergan Ltd
- 7.1.1 Company Overview
7.2 Integra LifeSciences Corp
- 7.2.1 Company Overview
7.3 MiMedx Group Inc
- 7.3.1 Company Overview
7.4 Organogenesis Holdings Inc
- 7.4.1 Company Overview
7.5 Smith & Nephew Plc
- 7.5.1 Company Overview
7.6 LifeNet Health Inc
- 7.6.1 Company Overview

8 Tissue Engineered Skin Substitutes Market Pipeline Products

9 Recent Developments

9.1 Corporate Communications
- 9.1.1 Nov 20, 2025: FibroBiologics Receives HREC Approval for Phase 1/2 Clinical Trial for CYWC628
- 9.1.2 Oct 14, 2025: Celularity Publishes Phase 2 Clinical Trial Results on PDA-002 for Diabetic Foot Ulcers
- 9.1.3 Oct 07, 2025: CureVision Rethinks Wound Healing and Scales with Strategic Partners
- 9.1.4 Oct 01, 2025: CMS Expands Access to RECELL for Patients with Non-Burn Acute Wounds
9.2 Government and Public Interest
- 9.2.1 Nov 10, 2025: MIMEDX to Participate in Upcoming Investor Conferences
- 9.2.2 Sep 23, 2025: FibroBiologics To Present At 2025 Cell & Gene Meeting On The Mesa
- 9.2.3 Aug 28, 2025: Surrozen to Present at Upcoming Healthcare Investor Conference
9.3 Other Significant Developments
- 9.3.1 Nov 19, 2025: HMP Global Launches CTP News Desk for Real-Time Updates on Cellular and Tissue-Based Products
- 9.3.2 Nov 10, 2025: MediMax Global Becomes Exclusive Distributor of Kent Imaging's SnapshotNIR Device in the UK and Eire
- 9.3.3 Oct 02, 2025: BioStem Technologies Partners with Florida Panthers for 13th Season of 'Heroes Among Us' Program
- 9.3.4 Oct 01, 2025: CMS Expands Access to RECELL for Patients with Non-Burn Acute Wounds
9.4 Product News
- 9.4.1 Nov 20, 2025: FibroBiologics Receives HREC Approval for Phase 1/2 Clinical Trial for CYWC628
- 9.4.2 Nov 19, 2025: HMP Global Launches CTP News Desk for Real-Time Updates on Cellular and Tissue-Based Products
- 9.4.3 Nov 12, 2025: European Society of Medicine Publishes Article on Small Mobile Stem Cells
- 9.4.4 Nov 03, 2025: Johnson & Johnson Confirms Durability of IVL in Complex Below-the-Knee Anatomy
- 9.4.5 Oct 14, 2025: Celularity Publishes Phase 2 Clinical Trial Results on PDA-002 for Diabetic Foot Ulcers
- 9.4.6 Oct 13, 2025: BioLargo Subsidiary Clyra Medical Advances Toward Product Launches and Expansion
- 9.4.7 Oct 01, 2025: CMS Expands Access to RECELL for Patients with Non-Burn Acute Wounds
- 9.4.8 Sep 30, 2025: Merakris Therapeutics Secures FDA Agreement for Type C Meeting to Discuss MTX-001 Development
- 9.4.9 Sep 12, 2025: New ICU Study Finds Adhesive Technique Reduces Jugular Line Dressing Failures
- 9.4.10 Sep 10, 2025: Kane Biotech Completes Enrollment in U.S. Case Series Studies of Its Revyve Antimicrobial Wound Gel and Spray
9.5 Strategy And Business Planning
- 9.5.1 Nov 10, 2025: MediMax Global Becomes Exclusive Distributor of Kent Imaging's SnapshotNIR Device in the UK and Eire
- 9.5.2 Nov 05, 2025: Biostem Technologies Secures Land Purchase at Florida Atlantic University Research Park for Future Headquarters
- 9.5.3 Oct 13, 2025: BioLargo Subsidiary Clyra Medical Advances Toward Product Launches and Expansion
- 9.5.4 Oct 07, 2025: CureVision Rethinks Wound Healing and Scales with Strategic Partners
- 9.5.5 Sep 24, 2025: Alira Health Becomes First Platinum CRO Partner of the Wound Care Collaborative Community
- 9.5.6 Sep 14, 2025: Avita Medical Receives CE Mark for Recell GO, Enabling Commercialization Across Europe

10 Appendix

10.1 Research Methodology
- 10.1.1 Coverage
- 10.1.2 Secondary Research
- 10.1.3 Primary Research
- 10.1.4 Market Modeling and Forecasting
- 10.1.5 Company Share Analysis
- 10.1.6 Benchmarking
10.2 GlobalData Consulting
10.3 Contact Us
10.4 Disclaimer

Product Code: GDME21584CRDB

List of Table

List of Tables

Table 1: Tissue Engineered Skin Substitutes Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2018-2033
Table 2: Tissue Engineered Skin Substitutes Market, North America, Revenue ($m), USD Constant, 2018-2033
Table 3: Tissue Engineered Skin Substitutes Market, North America, Volume (Units), 2018-2033
Table 4: Tissue Engineered Skin Substitutes Market, North America, Volume (Units), 2018-2033
Table 5: Tissue Engineered Skin Substitutes Market, North America, Company Share by Revenue ($m), 2024
Table 6: Tissue Engineered Skin Substitutes Market, Canada, Revenue ($m), USD Constant, 2018-2033
Table 7: Acellular Skin Substitutes Market, Canada, Revenue ($m), USD Constant, 2018-2033
Table 8: Cellular Skin Substitutes Market, Canada, Revenue ($m), USD Constant, 2018-2033
Table 9: Tissue Engineered Skin Substitutes Market, Canada, Volume (Units), 2018-2033
Table 10: Acellular Skin Substitutes Market, Canada, Volume (Units), 2018-2033
Table 11: Cellular Skin Substitutes Market, Canada, Volume (Units), 2018-2033
Table 12: Tissue Engineered Skin Substitutes Market, Canada, Average Price ($), 2018-2033
Table 13: Tissue Engineered Skin Substitutes Market, Canada, Company Share by Revenue ($m), 2024
Table 14: Tissue Engineered Skin Substitutes Market, Mexico, Revenue ($m), USD Constant, 2018-2033
Table 15: Acellular Skin Substitutes Market, Mexico, Revenue ($m), USD Constant, 2018-2033
Table 16: Cellular Skin Substitutes Market, Mexico, Revenue ($m), USD Constant, 2018-2033
Table 17: Tissue Engineered Skin Substitutes Market, Mexico, Volume (Units), 2018-2033
Table 18: Acellular Skin Substitutes Market, Mexico, Volume (Units), 2018-2033
Table 19: Cellular Skin Substitutes Market, Mexico, Volume (Units), 2018-2033
Table 20: Tissue Engineered Skin Substitutes Market, Mexico, Average Price ($), 2018-2033
Table 21: Tissue Engineered Skin Substitutes Market, Mexico, Company Share by Revenue ($m), 2024
Table 22: Tissue Engineered Skin Substitutes Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 23: Acellular Skin Substitutes Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 24: Cellular Skin Substitutes Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 25: Tissue Engineered Skin Substitutes Market, United States, Volume (Units), 2018-2033
Table 26: Acellular Skin Substitutes Market, United States, Volume (Units), 2018-2033
Table 27: Cellular Skin Substitutes Market, United States, Volume (Units), 2018-2033
Table 28: Tissue Engineered Skin Substitutes Market, United States, Average Price ($), 2018-2033
Table 29: Tissue Engineered Skin Substitutes Market, United States, Company Share by Revenue ($m), 2024
Table 30: Tissue Engineered Skin Substitutes Market Pipeline Products
Table 31: Total Number of Primary Research Participants, Wound Care Management Market, by Country

List of Figure

List of Figures

Figure 1: Tissue Engineered Skin Substitutes Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2018-2033
Figure 2: Tissue Engineered Skin Substitutes Market, North America, Revenue ($m), USD Constant, 2018-2033
Figure 3: Tissue Engineered Skin Substitutes Market, North America, Volume (Units), 2018-2033
Figure 4: Tissue Engineered Skin Substitutes Market, North America, Volume (Units), 2018-2033
Figure 5: Tissue Engineered Skin Substitutes Market, North America, Company Share (%), 2024
Figure 6: Tissue Engineered Skin Substitutes Market, Canada, Revenue ($m), USD Constant, 2018-2033
Figure 7: Acellular Skin Substitutes Market, Canada, Revenue ($m), USD Constant, 2018-2033
Figure 8: Cellular Skin Substitutes Market, Canada, Revenue ($m), USD Constant, 2018-2033
Figure 9: Tissue Engineered Skin Substitutes Market, Canada, Volume (Units), 2018-2033
Figure 10: Acellular Skin Substitutes Market, Canada, Volume (Units), 2018-2033
Figure 11: Cellular Skin Substitutes Market, Canada, Volume (Units), 2018-2033
Figure 12: Tissue Engineered Skin Substitutes Market, Canada, Company Share (%), 2024
Figure 13: Tissue Engineered Skin Substitutes Market, Mexico, Revenue ($m), USD Constant, 2018-2033
Figure 14: Acellular Skin Substitutes Market, Mexico, Revenue ($m), USD Constant, 2018-2033
Figure 15: Cellular Skin Substitutes Market, Mexico, Revenue ($m), USD Constant, 2018-2033
Figure 16: Tissue Engineered Skin Substitutes Market, Mexico, Volume (Units), 2018-2033
Figure 17: Acellular Skin Substitutes Market, Mexico, Volume (Units), 2018-2033
Figure 18: Cellular Skin Substitutes Market, Mexico, Volume (Units), 2018-2033
Figure 19: Tissue Engineered Skin Substitutes Market, Mexico, Company Share (%), 2024
Figure 20: Tissue Engineered Skin Substitutes Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 21: Acellular Skin Substitutes Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 22: Cellular Skin Substitutes Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 23: Tissue Engineered Skin Substitutes Market, United States, Volume (Units), 2018-2033
Figure 24: Acellular Skin Substitutes Market, United States, Volume (Units), 2018-2033
Figure 25: Cellular Skin Substitutes Market, United States, Volume (Units), 2018-2033
Figure 26: Tissue Engineered Skin Substitutes Market, United States, Company Share (%), 2024